Ocumension Therapeutics
HKEX:1477.HK
Overview | Financials
Company Name | Ocumension Therapeutics |
Symbol | 1477.HK |
Currency | HKD |
Price | 5.43 |
Market Cap | 4,370,930,085 |
Dividend Yield | 0% |
52-week-range | 4.13 - 7.94 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Ye Liu |
Website | https://www.ocumension.com |
An error occurred while fetching data.
About Ocumension Therapeutics
Ocumension Therapeutics, together with its subsidiaries, operates as an ophthalmic pharmaceutical platform company in the People's Republic of China. The company discovers, develops, and commercializes therapies for ophthalmic patients. It offers drugs for the treatment of blepharitis, infective and allergic conjunctivitis, dry eye, cataract, glaucoma and ocular hypertension, postoperative inflammation,
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD